Propanc Biopharma begins prep for Phase 1b cancer therapy trial in Australia

August 18, 2026 8:30 AM

Propanc Biopharma, Inc. (Nasdaq: PPCB) has announced the start of preparatory activities for a Phase 1b clinical study of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found